Ryan Everett Fecteau MD PhD
Urologic Cancer
Assistant Professor in Radiation Oncology
Join to view full profile
20 Duke Medicine CirBOX 3085Durham, NC 27710
Phone+1 919-668-5640
Fax+1 919-668-7345
Dr. Fecteau is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Ryan Fecteau is a radiation oncologist based in Durham, NC, specializing in urologic cancer. He completed his residency at Memorial Sloan Kettering Cancer Center and New York-Presbyterian Hospital, following an internship at Case Western Reserve University. Currently, he serves as an Assistant Professor and Radiation Oncologist at Duke University Health System and Medical Center. Dr. Fecteau has contributed to several publications, including works on prostate cancer management and genetic research related to esophageal adenocarcinoma.
Education & Training
Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2021 - 2022
New York-Presbyterian Hospital (Cornell Campus)Residency, Radiation Oncology, 2018 - 2021
Case Western Reserve University/University Hospitals Cleveland Medical CenterInternship, Preliminary Year, 2017 - 2018
Case Western Reserve University School of MedicineClass of 2017
Certifications & Licensure
MA State Medical License 2026 - 2027
NC State Medical License 2022 - 2027
NY State Medical License 2021 - 2023
OH State Medical License 2017 - 2020
American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- Comparative Economic Evaluation of Radical Prostatectomy, Radiation, and Ablative Techniques in the Management of Localized Prostate Cancer.Mahdi Mottaghi, Alireza Ghoreifi, Sriram Deivasigamani, Eric S Adams, Sudharshanan Balaji
Cancers. 2025-08-28 - Improvement of bullous pemphigoid following salvage radiation in PSA-recurrent prostate cancer: a potential paraneoplastic association.Michael Shen Lee, Donna Aline Culton, Ryan Everett Fecteau, Andrew Armstrong
BMJ Case Reports. 2025-07-10 - Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer.Ryan E Fecteau, Bridget F Koontz, Karen E Hoffman, Susan Halabi, Lauren E Howard
Prostate Cancer and Prostatic Diseases. 2025-06-01
Press Mentions
MPH Reopens Radiation Oncology DepartmentOctober 15th, 2025- Bill to Improve Dental Health Access Passes Unanimously in LegislatureJune 4th, 2021
- Expanding Access to Dental Care Is Good for Mainers and the EconomyApril 6th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
